{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:26:47Z","timestamp":1787218007756,"version":"build-2736575974"},"reference-count":34,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Oncol.","Current Oncology"],"abstract":"<jats:p>Background: Ovarian cancer is the eighth most common cancer in women worldwide. Prognosis in ovarian cancer patients is mainly affected by the complete resectability of the tumor at the time of surgery. Among the methods used to determine resectability are laparotomy, laparoscopy, and imaging techniques. In ovarian cancer patients, the Fagotti Score (FS) and Peritoneal Cancer Index (PCI) can be used during upfront diagnostic laparoscopy to quantify disease burden, resectability, and prognosis. Methods: The aim of this retrospective study was to assess the FS and PCI as tools for predicting optimal cytoreduction (R = 0, &lt;1) and correctly assigning patients for primary debulking surgery (PDS) or interval debulking surgery (IDS). An ROC was used to compare the accuracy of both FS and PCI scores for assessing resectability. Diagnostic measures for both were calculated. Results: A total of 45 patients were ultimately included in this study. The area under the curve was 0.801 for the FS and 0.705 for the laparoscopic PCI, with an optimal cut-off score of 24.5. In our cohort, the FS demonstrated a sensitivity of 90%, a specificity of 64%, a PPV of 66.7%, and an NPV of 88.9%. Similarly, using a cut-off of 24.5, the PCI demonstrated a sensitivity of 80%, a PPV of 59.3%, and an NPV of 56%. Conclusions: Laparoscopic PCI is a useful tool for predicting resectability in ovarian cancer patients. However, when compared with the PCI, it seems that the FS performs better as a predictive score for resectability.<\/jats:p>","DOI":"10.3390\/curroncol33080490","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:10:20Z","timestamp":1787213420000},"page":"490","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fagotti Score (FS) Compared with Peritoneal Cancer Index (PCI) for Preoperative Assessment of Optimal Cytoreduction in Upfront Laparoscopy"],"prefix":"10.3390","volume":"33","author":[{"given":"Dimitrios","family":"Tsolakidis","sequence":"first","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, \u201cPapagergiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthalia","family":"Markopoulou","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, \u201cPapagergiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Thomakos","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Haidopoulos","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2518-5657","authenticated-orcid":false,"given":"Dimitrios","family":"Zouzoulas","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, \u201cPapagergiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-5224","authenticated-orcid":false,"given":"Vasilis","family":"Theodoulidis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, \u201cPapagergiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-4708","authenticated-orcid":false,"given":"Kimon","family":"Chatzistamatiou","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, \u201cPapagergiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Topalidou","sequence":"additional","affiliation":[{"name":"Radiation Oncology, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2545-8926","authenticated-orcid":false,"given":"Eleni","family":"Timotheadou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigoris","family":"Grimbizis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, \u201cPapagergiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: A review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00432-025-06277-9","article-title":"Global, regional and national burden of ovarian cancer in women aged 45+ from 1990 to 2021 and projections for 2050: A systematic analysis based on the 2021global burden of disease study","volume":"151","author":"Ren","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Li, Y., Song, W., Gao, P., Guan, X., Wang, B., Zhang, L., Yao, Y., Guo, Y., Wang, Y., and Jiang, S. (2025). Global, regional and national burden of breast, cervical, uterine and ovarian cancer and their risk factors among women from 1990 to 2021 and projections to 2050: Findings from the global burden of disease study. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-13741-9"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-026-00686-x","article-title":"Ovarian Cancer","volume":"12","author":"Scott","year":"2026","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Biernacka, K., Lukasiewixz, H., Samulak, D., Piekarska, E., Romanowicx, H., and Malowska, M. (2025). Ovarian cancer-epidemiology, classification, pathogenesis, treatment and estrogem receptors molecular backgrounds. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104611"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102074","DOI":"10.1016\/j.canep.2021.102074","article-title":"Ovarian cancer survival by stage, histotype and pre-diagnostic lifestyle factors in the prospective UK Million Women Study","volume":"76","author":"Gaitskell","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Miceli, V., Gennarini, M., Tomao, F., Cupertino, A., Lombardo, D., Palaia, I., Curti, F., Riccardi, S., Ninkova, R., and Maccioni, F. (2023). Imaging of peritoneal carcinomatosis in advanced ovarian cancer: CT, MRI, radiomic features and resectability criteria. Cancers, 15.","DOI":"10.3390\/cancers15245827"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lamiman, K., Silver, M., Hayek, J., Hanusek, R., Sarmiento, L., Kim, M., Goncalves, N., and Alagkiozidis, I. (2025). Trends in surgical outcomes and overall survival among women undergoing debulking surgery for advanced ovarian cancer in the U.S: Analysis of the national cancer database. Cancers, 17.","DOI":"10.3390\/cancers17172884"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"29","author":"Colombo","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP concesus conference recommendations on ovarian cancer pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrclinonc.2015.26","article-title":"A framework for a personalized surgical approach for ovarian cancer","volume":"12","author":"Nick","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"LBA5500","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA5500","article-title":"Trust trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"43","author":"Mahner","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111355","DOI":"10.1016\/j.ejso.2025.111355","article-title":"Surgical timing in advanced ovarian cancer during the TRUST trial era: A systematic review, meta-analysis and study-level meta-regression of randomized controlled trials","volume":"52","author":"Tius","year":"2025","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pinto, P., Burgetova, A., Cibula, D., Haldorsen, I.S., Indrielle-Kelly, T., and Fischerova, D. (2023). Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review. Cancers, 15.","DOI":"10.3390\/cancers15061904"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-015-0379-8","article-title":"Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer","volume":"17","author":"Fagotti","year":"2016","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","article-title":"Laparoscopy to predict the results of primary cytoreductive surgery in patients with advanced ovarian cancer: A randomized controlled trial","volume":"35","author":"Rutten","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A Laparoscopy-Based Score To Predict Surgical Outcome in Patients With Advanced Ovarian Carcinoma: A Pilot Study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Climent, M.T., Serra, A., Gilabert-Estell\u00e9s, J., Gilabert-Aguilar, J., and Lueca, A. (2021). Comparison of peritoneal carcinomatosis scoring methods in prediciting resectability and prognosis in gynaecologic malignancies. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122553"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Markopoulou, E., Tsolakidis, D., Timotheadou, E., and Grimbizis, G. (2026). Fagotti score in comparison with peritoneal cancer index (PCI) for assessing preoperatively optimal cytoreduction in upfront laparoscopy. Int. J. Gynecol. Cancer, 36.","DOI":"10.1016\/j.ijgc.2025.103860"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jaquet","year":"1996","journal-title":"Cancer Treat. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.ejso.2021.03.233","article-title":"Peroperative scoring systems for predicting the outcome of cytoreductive surgery in advanced-stage ovarian cancer\u2014A systematic review","volume":"47","author":"Engbersen","year":"2021","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Di Donna, M.C., Cucinella, G., Zaccaria, G., Re, G.L., Crapanzano, A., Salerno, S., Giallombardo, V., Sozzi, G., Fagotti, A., and Scambia, G. (2023). Concordance of Radiological, Laparoscopic and Laparotomic Scoring to Predict Complete Cytoreduction in Women with Advanced Ovarian Cancer. Cancers, 15.","DOI":"10.3390\/cancers15020500"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Konidari, M., Goutysoyianni, S., Thomakos, N., Lymperopoulou, G., Tzavara, C., Pergaliotis, V., Rodolakis, A., Moulopoulos, L.A., and Bourgioti, C. (2026). Prediction of resectability of Periotoneal Cancer Index (PCI) and Fagotti Score on MRI. Cancers, 18.","DOI":"10.3390\/cancers18010165"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ygyno.2015.03.049","article-title":"Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care","volume":"137","author":"Nick","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_27","first-page":"CD009786","article-title":"Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer","volume":"3","author":"Rutten","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1245\/s10434-020-08664-7","article-title":"ASO Author reflections: Use of peritoneal cancer index (PCI) to evaluate carcinomatosis in ovarian cancer","volume":"27","author":"Stalberg","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00404-020-05874-y","article-title":"Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer","volume":"303","author":"Angeles","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/IGC.0b013e3182a616a7","article-title":"Accuracy and Reproducibility of the Peritoneal Cancer Index in Advanced Ovarian Cancer During Laparoscopy and Laparotomy","volume":"23","author":"Gouy","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2024.10.003","article-title":"Prediction of non-resectability in tubo-ovarian cancer patients using Peritoneal Cancer Index\u2014A prospective multicentric study using imaging (ISAAC study)","volume":"191","author":"Pinto","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"632.e1","DOI":"10.1016\/j.ajog.2024.06.047","article-title":"Prediction of nonresectability using the updated predictive index value model assessed by imaging and surgery in tubo-ovarian cancer: A prospective multicenter ISAAC study","volume":"231","author":"Moro","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101014","DOI":"10.1016\/j.currproblcancer.2023.101014","article-title":"Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: A meta-analysis","volume":"47","author":"Yang","year":"2023","journal-title":"Curr. Probl. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, S., Liu, S., Liu, F., Guo, Y., and Han, F. (2024). Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer? A systematic review and meta-analysis based on the latest evidence. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1421828"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/490\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:03:00Z","timestamp":1787216580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["curroncol33080490"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33080490","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}